================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): September 8, 2000
CLINICOR, INC.
(Exact Name of Registrant as Specified in Charter)
Commission File No. 0-21721
Nevada 88-0309093
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation) Identification No.)
1717 West Sixth Street, Suite 400, Austin, Texas 78703
(Address of Principal Executive Offices) (ZipCode)
(512) 344-3300
(Registrant's Telephone Number, Including Area Code)
Item 5. Other Events.
As discussed in Clinicor, Inc.'s (the "Company") previous Form 10-KSB and
Form 10-QSB filings over the last six months, the Company has faced serious
liquidity problems and, accordingly, has been attempting to raise additional
capital and has pursued other strategic alternatives, including sale of the
Company. As discussed in the Company's most recent Form 10-QSB for the quarter
ended June 30, 2000, the Company had depleted all of its cash reserves and faced
continued losses. The Company has not been successful in raising additional
capital or in finding a buyer. Due to its inability to fund continuing
operations, the Company has ceased operations, its employees have terminated and
the lease for its primary place of business has expired effective September 8,
2000. The Company is in discussions with a third party to sell certain assets;
however, there can be no assurances that a sale will be completed. In any event,
proceeds from an asset sale would not be adequate to provide any funds to the
Company's preferred or common shareholders. The Company intends in the immediate
future to file to terminate the registration of its common stock under Section
12(g) of the Securities Exchange Act of 1934 and does not expect to make any
further filings with the Securities and Exchange Commission or to issue further
public announcements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CLINICOR, INC.
Date September 14, 2000 By /s/ Robert S. Sammis
-----------------------------------
Robert S. Sammis
President
(Principal Executive Officer)